MediciNova CEO Provides Shareholder UpdateLA JOLLA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (
NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), today provides shareholders an update on key findings from the recent topline results of its Phase 2 clinical trial evaluating MN-001 for the treatment of nonalcoholic fatty liver disease and hypertriglyceridemia associated with type 2 diabetes mellitus in the following letter from CEO Yuichi Iwaki, Ph.D.
Point Funds 30,000th Homeowner, Surpassing $3 Billion in Home Equity InvestmentsPoint has doubled the number of homeowners it serves in under 18 months and now operates in five new states: Kentucky, Nebraska, Iowa, Kansas, and Mississippi
Origence named California Credit Union League’s Supplier of the YearCompany recognized for its commitment, excellence and contributions to the credit union movement
Submittable Announces Pratyush Rai as Chief Technology OfficerFormer Great Gray and Auction Technology Group CTO to lead Submittable's platform, data and AI strategy
Dmitry Shubov Consulting Advises Southeast Asian Firms on U.S. Expansion Readiness as ASEAN Digital Economy Growth AcceleratesFREMONT, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- As Southeast Asia’s digital economy continues to expand, more businesses across the region are starting to look seriously at the U.S. as their next growth market. In response, Dmitry Shubov Consulting, a startup consulting firm, has issued a strategic analysis outlining the legal and structural groundwork Southeast Asian technology and service firms should address before expanding into the U.S. The timing follows ASEAN’s 2026 Digital Economy Framework Agreement (DEFA) study, which projects the region’s digital economy could reach US$2 trillion by 2030. For many founders, interest in the U.S. market starts with growth. New customers, stronger partnerships, and a bigger commercial footprint. But making that move successfully usually depends on work happening behind the scenes first. Business structure, contracts, intellectual property, and internal documentation all play a role in whether expansion moves forward smoothly or stalls under pressure.Dmitry Shubov Consulting works with internationally focused companies on the planning needed to make cross-border growth more practical and less reactive. As more Southeast Asian businesses explore U.S. expansion, the firm is encouraging leadership teams to prepare early by looking closely at entity structure, governance, commercial agreements, and day-to-day operational readiness.That process may include choosing the right U.S. business structure, clarifying responsibilities between related entities, reviewing customer agreements, organizing IP records, and making sure the company is prepared for banking, diligence, and partnership conversations.“Many companies feel ready to grow internationally because the demand is there,” said Dmitry Shubov, founder of Dmitry Shubov Consulting. “But once expansion starts, it becomes clear very quickly whether the business has the right structure behind it. When that groundwork is done early, companies are usually in a much better position to move with confidence.”The firm notes that many delays in cross-border expansion are avoidable and often come down to preparation rather than opportunity. With more Southeast Asian companies thinking globally, market-entry readiness is becoming a more important part of growth planning. For more information, visit DmitryShubovConsulting.com.
Flyte Aviation Reports Record Preliminary Third Quarter Revenue of $2.15 Million, Up 110% Quarter Over QuarterNEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Flyte Aviation, Inc. (NYSE American: VJET), a technology-enabled private aviation company, today announced record preliminary third quarter 2026 revenue of approximately $2.15 million. This represents an increase of approximately 110%, quarter-over-quarter, compared with $1.02 million in the second quarter of 2026.
Gates Foundation and Wellcome Leap Commit $100 Million to Reduce Global Stillbirth RatesBERLIN, Oct. 12, 2026 (GLOBE NEWSWIRE) -- The Gates Foundation and Wellcome Leap today announced a new initiative called Uzima: A Stillbirth Prevention Program, which aims to demonstrate that stillbirth rates can be reduced by half over the next decade across select countries. Uzima will identify, validate, and scale promising innovations that can help families and health workers recognize risks earlier and respond to complications during pregnancy and childbirth. By showing what works in partnership with different health systems, the program will create a model for bringing these advances to women and babies around the world.
Airbus U740 Valkyrie Uncrewed Combat Aircraft Takes off for First European Test FlightSAN DIEGO, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc., (
NASDAQ: KTOS) a technology company in the defense, national security and global markets, and Airbus announced the successful completion of the first flight of the “U740-Valkyrie” in Europe. This key milestone confirms that Airbus and Kratos are on track to deliver a combat-ready uncrewed Collaborative Combat Aircraft (CCA) by 2029, addressing the operational requirements of the German and other European Armed Forces.
DHT Holdings, Inc. Business UpdateHAMILTON, BERMUDA, October 12, 2026 – DHT Holdings, Inc. (
NYSE:DHT) (“DHT” or the “Company”) today provides the following business update:
BROAD ARROW ZOUTE CONCOURS SALE BECOMES THE HIGHEST GROSSING COLLECTOR CAR AUCTION IN BELGIAN HISTORYBroad Arrow celebrating success of second annual Zoute Concours Auction in collaboration with Zoute Grand Prix with €34.6 million in total sales and 91 percent sell-through rate | 2015 Ferrari LaFerrari the most valuable car ever sold at auction in Belgium with a final price of €5.181.250 | 2015 Porsche 918 Spyder Weissach Package and 2015 McLaren P1 complete ‘Holy Trinity’ sale | Unique BMW M5 W10 prototype driven by Dr. Ferdinand Piëch breaks world record for price of an E39 BMW at €411.250 | Complete results from Broad Arrow’s Zoute Concours Auction now available at broadarrowauctions.com
ProLogium and Rimac Technology Advance Next-Generation EV Battery DevelopmentConcept mockup to be showcased at the 2026 Paris Motor Show, with functional battery segment development planned as the next phase of cell and system integration work
Kosmos Energy to Host Third Quarter 2026 Results and Webcast on November 2, 2026DALLAS, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its third quarter 2026 results:
Gibraltar and ADI Foundation Explore Landmark Multi-Currency Stablecoin Consortium in GibraltarGIBRALTAR and ABU DHABI, United Arab Emirates, Oct. 12, 2026 (GLOBE NEWSWIRE) -- His Majesty’s Government of Gibraltar and ADI Foundation have signed a Memorandum of Understanding to explore establishing a multi-currency stablecoin consortium, marking a significant step in building regulated digital financial infrastructure connecting international markets.
GTCFX-PR 5-GTCPrime Signs Off From iFX Expo Hong Kong 2026 After Two Days of Insight and ConnectionDUBAI, United Arab Emirates, Oct. 12, 2026 (GLOBE NEWSWIRE) -- GTCPrime has closed out its participation as Gold Sponsor at iFX Expo Hong Kong 2026, held on October 8-9 at the Hong Kong Convention and Exhibition Centre. Over the two days, the GTCPrime team welcomed clients, partners, and industry peers at Booth 14 to discuss market developments and the changing needs of investors across Asia-Pacific.
Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesityTwo oral presentations at AHA Hypertension 2026 demonstrate the pronounced efficacy of aprocitentan in two groups of patients with notoriously difficult to control hypertension from the PRECISION study: patients with obesity and patients across the cardiovascular-kidney-metabolic (CKM) continuum.
VALLOUREC AWARDED MAJOR CONTRACT BY TOTALENERGIES FOR THE ABSHERON GAS FIELD IN AZERBAIJANVALLOUREC AWARDED MAJOR CONTRACT BY TOTALENERGIES FOR THE ABSHERON GAS FIELD IN AZERBAIJAN
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in ChinaBEIJING, Oct. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved its Investigational New Drug (IND) application for ICP-B161, a bispecific antibody targeting TL1A and IL-23p19, for the treatment of autoimmune diseases, including inflammatory bowel disease (IBD). ICP-B161 is InnoCare’s fifth novel drug candidate to enter clinical development in 2026.
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026SAN DIEGO, Oct. 11, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, will host an investor call and live webcast to review top-line data from Cohort 1, a gluten-challenge study assessing prevention of mucosal damage, of the global Phase 1b trial of investigational ANB033, a CD122 antagonist, in celiac disease on Monday, Oct. 12, 2026, at 8:30am ET/5:30am PT.
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records- In an independent, propensity score-matched analysis of 2,684 individuals living with ATTR-CM from Epic COSMOS, the largest U.S. electronic health record database, acoramidis was associated with a statistically significant 18% lower risk of a composite of death, all-cause hospitalization, new-onset atrial fibrillation, and diuretic intensification versus tafamidis (HR 0.82; 95% CI 0.73-0.93; p<0.01)
Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show• Stellantis offered an exclusive preview of six of the nine concept cars set to debut at the Paris Motor Show, October 12-18
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026– Significant performance improvement seen across all subtypes of advanced precancerous lesions, which are important to detect for potential colorectal cancer prevention –
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1
‘Moms Offering More’ Launches Limited Crewneck Collaboration With Archewell Philanthropies in Support of Alliance for MomsVANCOUVER, Oct. 11, 2026 (GLOBE NEWSWIRE) -- Moms Offering More, a community of women supporting mothers and historically underserved families across Canada and the United States, today launched a limited-edition crewneck sweatshirt created in collaboration with Archewell Philanthropies.
Pomona College launches $530M campaign to expand access; breaks ground on Center for Global EngagementThe Originals Campaign represents a continued investment in educational and research opportunities for students and faculty.
HDFC BANK DEADLINE TUESDAY: Bragar Eagel & Squire, P.C. Urges HDFC Bank Limited Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13thBragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In HDFC Bank (HDB) To Contact Them Directly To Discuss Their Options
UWMC DEADLINE TUESDAY: UWM Holdings Corporation Investors Have Until October 13th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff RoleBragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In UWM To Contact Them Directly To Discuss Their Options
URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aardvark (AARD) To Contact Him Directly To Discuss Their Options
SMPL URGENT DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds The Simply Good Foods Company Investors of The Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm Before October 13thIf you purchased or acquired Simply Good Foods common stock between October 24, 2024 and April 8, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
Corza Medical Launches Expanded Blink Single-Use Custom Packs and First-of-Its-Kind Microsurgical Knife Manufacturing ProcessBOULDER, Colo., Oct. 10, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Blink Single-Use Custom Packs offering and a first-of-its-kind automated manufacturing process for Sharpoint® microsurgical knives at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting taking place October 10 - 12 in New Orleans.
Vannor Launches Agentic Marketing After AI Agents Drive 30-Fold Increase in First-Page Google RankingsVannor’s autonomous AI agents research, create, review, publish and improve marketing content while running entirely on company-owned NVIDIA AI infrastructure.
Green Thumb Opens RISE Dispensary in Cape Coral, Expanding Florida Footprint to 25 LocationsCHICAGO and VANCOUVER, British Columbia, Oct. 10, 2026 (GLOBE NEWSWIRE) -- RISE Dispensaries, an industry-leading cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of RISE Dispensary Cape Coral, Florida, on October 10. Located at 928 NE Pine Island Road, RISE Dispensary Cape Coral is Green Thumb’s 25th retail location in Florida, adding to the Company’s network of more than 120 stores nationwide.
CGTN: How China uses digital tech to empower women globallyBEIJING, Oct. 10, 2026 (GLOBE NEWSWIRE) -- CGTN published an article on China's efforts to empower women through digital technologies. Drawing on Peng Liyuan's remarks at the 2026 UNESCO Prize for Girls' and Women's Education award ceremony on Friday, the article highlights China's efforts to advance women's digital skills, promote gender equality and expand international cooperation to bridge the gender digital divide.
Sigenergy Unveils the Latest Energy Solutions at Malaysia’s IGEM 2026KUALA LUMPUR, Malaysia, Oct. 10, 2026 (GLOBE NEWSWIRE) -- Sigenergy is making its third appearance at the International Greentech & Eco Products Exhibition & Conference Malaysia (IGEM), showcasing its latest intelligent energy solutions and strengthening strategic partnerships across the Malaysian market.
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)WESTLAKE VILLAGE, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, today announced new clinical data related to Furoscix ReadyFlow (furosemide injection) that will be presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2026, taking place October 9-12, 2026, in Phoenix.
Coastal Community Bank Invests in Workforce Housing Through Koz Development's PNW Attainable Workforce Housing FundInvestment supports attainable housing for working individuals and families and helps leverage innovative public-private-philanthropic housing programs.
Brookfield Infrastructure Corporation Announces New Date for Meeting on Proposed Corporate SimplificationBROOKFIELD, NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Corporation (“BIPC”) (TSX, NYSE: BIPC) today announced a new date for the special meeting of shareholders of BIPC (the “Shareholders’ Meeting” or the “Meeting”) in respect of the proposed corporate structure simplification (the “Simplification”). While votes received to date demonstrate support for the Simplification, the new date will allow additional time for shareholders to submit their votes.
Brookfield Renewable Partners Announces New Date for Meeting on Proposed Corporate SimplificationBROOKFIELD, NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable Partners (“BEP”) (TSX: BEP.UN, NYSE: BEP) today announced a new date for the special meeting of unitholders of BEP (the “Unitholders’ Meeting” or the “Meeting”) in respect of the proposed corporate structure simplification (the “Simplification”). Votes received to date demonstrate overwhelming support for the Simplification, with over 99.7% of votes cast in favor. The new date will provide additional time for unitholders to participate and help achieve the required voting threshold to proceed with the Simplification, which we believe is in the best interests of all securityholders.
LigoLab Introduces AI-Assisted Voice Interface for Anatomic Pathology WorkflowsGLENDALE, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- LigoLab, a provider of laboratory information system (LIS) and laboratory revenue cycle management solutions, has introduced LigoLab Voice, an AI-assisted, hands-free interface integrated directly into its anatomic pathology LIS. The new capability enables voice-enabled documentation and workflow control, allowing pathologists and grossing technologists to use spoken commands for supported LIS functions without repeatedly switching between specimen handling or diagnostic work and manual software controls.
HBT Financial, Inc. to Announce Third Quarter 2026 Financial Results on October 26, 2026BLOOMINGTON, Ill., Oct. 09, 2026 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (
NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company, today announced that it will issue its third quarter 2026 financial results before the market opens on Monday, October 26, 2026. A copy of the press release announcing the third quarter 2026 financial results and an investor presentation will be made available on the Company’s investor relations website at https://ir.hbtfinancial.com.
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency NoticeNANCHANG, China, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (
NASDAQ: RYET) (the "Company") today announced that it received a written notice dated October 7, 2026 from Nasdaq stating that the closing bid price of its ordinary shares was below $1.00 per share for 30 consecutive business days, from August 25 through October 6, 2026. Accordingly, the Company does not meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Brookfield Corporation to Host Third Quarter 2026 Results Conference CallBROOKFIELD NEWS, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Brookfield Corporation (NYSE: BN, TSX: BN) will host its third quarter 2026 conference call and webcast on Thursday, November 12, 2026, at 10:00 a.m. (ET).
Axe Compute (NASDAQ: AGPU) to Ring the Nasdaq Stock Market Opening Bell on October 12, 2026Ceremony marks a milestone for the AI infrastructure company following significant commercial growth and continued expansion of its dedicated GPU compute capacity
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencySINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (
NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived, cell-based allogeneic immunotherapies, today announced that on October 6, 2026, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the closing bid price of the Company’s ordinary shares (the “Ordinary Shares”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Nasdaq notification letter has no current effect on the listing or trading of the Company’s Ordinary Shares on Nasdaq.
Base Electron Corp. Confidentially Submits Draft Registration Statement for Proposed Initial Public OfferingPLANO, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Base Electron Corp., a power infrastructure company developing grid-connected generation assets for hyperscale data center applications, has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.
Artisan Partners Asset Management Inc. Reports September 2026 Assets Under ManagementMILWAUKEE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (
NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of September 30, 2026 totaled $168.7 billion. Artisan Funds and Artisan Global Funds accounted for $90.2 billion of total firm AUM, while separate accounts and other AUM1 accounted for $78.5 billion.
EquipmentShare Responds to Inaccurate Short ReportCOLUMBIA, Mo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- EquipmentShare.com Inc (Nasdaq: EQPT) (“EquipmentShare”), a leader in connected jobsite technology and one of the largest construction equipment rental providers in the United States, today issued the following statement:
Coca-Cola Consolidated, Inc. Announces Fourth Quarter DividendCHARLOTTE, N.C., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (
NASDAQ: COKE) announced that its Board of Directors has declared a dividend for the fourth quarter of 2026 of $0.25 per share on shares of the Company's Common Stock and Class B Common Stock payable on November 6, 2026, to stockholders of record as of the close of business on October 23, 2026.
